A number of studies have found increased expression or upregulation of CCL5 in human epilepsy patients (Fabene et al., 2010; Srivastava et al., 2017), recapitulated in rodent models of pilocarpine (Arisi et al., 2015) and KA (Wolinski et al., 2022; Zhang et al., 2023) induced epilepsy. Here, CCL5 is linked to epilepsy.